DTL
TTPH

Dynamic Technology Lab’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Dynamic Technology Lab’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,765
Closed -$97K – 1458
2018
Q3 		$97K Buy
1,765
+1,012
+134% +$64.6K 0.01% 954
2018
Q2 		$54K Sell
753
-1,625
-68% -$115K 0.01% 923
2018
Q1 		$146K Buy
2,378
+1,477
+164% +$130K 0.02% 937
2017
Q4 		$114K Buy
+901
New +$115K 0.02% 930

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dynamic Technology Lab's TTPH Position: Q4 2018 in Review

Dynamic Technology Lab sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2018, closing a stake of 1,765 shares — an estimated $97K sold.

Dynamic Technology Lab first reported a position in TTPH in Q4 2017 and held it in 4 quarters. The position peaked at $146K in Q1 2018. 86 funds tracked by Wall St. Rank hold TTPH as of Q4 2018.

  • Dynamic Technology Lab reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,765 Tetraphase Pharmaceuticals, Inc. shares in Q4 2018, an estimated $97K.
  • Dynamic Technology Lab first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2017 and held it in 4 quarters.
  • Dynamic Technology Lab's Tetraphase Pharmaceuticals, Inc. position peaked at $146K in Q1 2018.
  • 86 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2018.

Based on Dynamic Technology Lab's 13F filing for Q4 2018, filed 13 Feb 2019.